Health Reporter Posted April 8, 2022 Report Share Posted April 8, 2022 Scoop: AbbVie drops IBS drug Viberzi in Canada, 'devastating' patients Endpoints News AbbVie has since confirmed to Endpoints that it is discontinuing Viberzi in Canada this year “as a result of our regular business prioritization review.” The drug will continue to be available in the US, as well as the UK — where Sam lives — with “no plans to discontinue,” a spokesperson said. It had already been discontinued in the EU back in 2020 at the request of Allergan, the drug’s initial manufacturer before the $63 billion AbbVie buyout that year. The pharma company declined to offer further explanation of its reasoning behind the discontinuation, adding that there “are alternative therapies available for patients.” View the full article Quote Link to comment Share on other sites More sharing options...
Jeffrey Roberts Posted August 18, 2022 Report Share Posted August 18, 2022 Update: Allergan Canada and/or Abbvie are considering providing continued access to Viberzi in Canada due to the number of calls that patients have been making to the Allergan Customer Care center. Patients can contact them 800-668-6424 or [email protected] Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.